Lv1
23 积分 2020-11-12 加入
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
1个月前
已完结
The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity
1个月前
已完结
ATG-101 Is a Tetravalent PD-L14-1BB BispecificAntibody That Stimulates Antitumor Immunity throughPD-L1 Blockade and PD-L1–Directed 4-1BB Activatio
1个月前
已完结
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2个月前
已完结
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
2个月前
已关闭
Current approaches for the purification of antibody-drug conjugates
2个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
4个月前
已完结
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
7个月前
已完结
Deep learning identifies DDR1 kinase inhibitors
7个月前
已完结
皖公网安备34019202002308
